ReviewWorld journal of surgery2009
Basic principles and technologies for deciphering the genetic map of cancer.
Review in World journal of surgery, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
10 citing papers in PubMed.
- Strategies for modern biomarker and drug development in oncology.Journal of hematology & oncology · 2014Review
- Genomic sequencing of key genes in mouse pancreatic cancer cells.Current molecular medicine · 2012Article
- Paired tumor and normal whole genome sequencing of metastatic olfactory neuroblastoma.PloS one · 2012Article
- Genetic variation and its role in malignancy.International journal of biomedical science : IJBS · 2011Article
- Defining the cancer master switch.World journal of surgery · 2011Review
- A primer on a hepatocellular carcinoma bioresource bank using the cancer genome atlas guidelines: practical issues and pitfalls.World journal of surgery · 2011Article
- Building a comprehensive genomic program for hepatocellular carcinoma.World journal of surgery · 2011Article
- Overview of the development of personalized genomic medicine and surgery.World journal of surgery · 2011Review
- Distinguishing between cancer driver and passenger gene alteration candidates via cross-species comparison: a pilot study.BMC cancer · 2010Article
- Single nucleotide polymorphism in RECQL and survival in resectable pancreatic adenocarcinoma.HPB : the official journal of the International Hepato Pancreato Biliary Association · 2009Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
The progress achieved in the field of genomics in recent years is leading medicine to adopt a personalized model in which the knowledge of individual DNA alterations will allow a targeted approach to cancer. Using pancreatic cancer as a model, we discuss herein the fundamentals that need to be considered for the high throughput and global identification of mutations. These include patient-related issues, sample collection, DNA isolation, gene selection, primer design, and sequencing techniques. We also describe the possible applications of the discovery of DNA changes to the approach of this disease and cite preliminary efforts where the knowledge has been translated into the clinical or preclinical setting.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.